news
06-01-2015, 02:15 AM
Flibanserin, which aims to restore lost libido in women, has been twice rejected by the F.D.A., which cited limited effectiveness as well as side effects. The drug will go before agency advisers again on Thursday.http://rss.nytimes.com/c/34625/f/642562/s/46cfdd52/sc/14/mf.gif
More... (http://rss.nytimes.com/c/34625/f/642562/s/46cfdd52/sc/14/l/0L0Snytimes0N0C20A150C0A60C0A10Cbusiness0Cgroups0E press0Efda0Eto0Eapprove0Ewomens0Eviagra0Bhtml0Dpar tner0Frss0Gemc0Frss/story01.htm)
More... (http://rss.nytimes.com/c/34625/f/642562/s/46cfdd52/sc/14/l/0L0Snytimes0N0C20A150C0A60C0A10Cbusiness0Cgroups0E press0Efda0Eto0Eapprove0Ewomens0Eviagra0Bhtml0Dpar tner0Frss0Gemc0Frss/story01.htm)